Publication Information

{'id': 'https://openalex.org/W4362545568', 'doi': 'https://doi.org/10.1158/1538-7445.am2023-3449', 'title': 'Abstract 3449: Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction', 'display_name': 'Abstract 3449: Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction', 'publication_year': 2023, 'publication_date': '2023-04-04', 'ids': {'openalex': 'https://openalex.org/W4362545568', 'doi': 'https://doi.org/10.1158/1538-7445.am2023-3449'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2023-3449', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5048871972', 'display_name': 'Gérald Gavory', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Gerald Gavory', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000230644', 'display_name': 'Mahmoud Ghandi', 'orcid': 'https://orcid.org/0000-0003-1897-2265'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Mahmoud Ghandi', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026331108', 'display_name': 'Anne-Cecile d’Alessandro', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Anne-Cecile d’Alessandro', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045437170', 'display_name': 'Débora Bonenfant', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Debora Bonenfant', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102904875', 'display_name': 'Maciej Cabanski', 'orcid': 'https://orcid.org/0000-0002-4522-3238'}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Maciej Cabanski', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040577712', 'display_name': 'Lisa Cantagallo', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Lisa Cantagallo', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074745892', 'display_name': 'Agustin Chicas', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Agustin Chicas', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100428424', 'display_name': 'Qian Chen', 'orcid': 'https://orcid.org/0000-0001-6077-6757'}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Qian Chen', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091184227', 'display_name': 'Anna Diesslin', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Anna Diesslin', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023026845', 'display_name': 'Christopher King', 'orcid': 'https://orcid.org/0000-0002-2400-5717'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Christopher King', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027954184', 'display_name': 'Vittoria Massafra', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Vittoria Massafra', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000381800', 'display_name': 'Rajiv Narayan', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Rajiv Narayan', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046012546', 'display_name': 'Arnaud Osmont', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Arnaud Osmont', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033647327', 'display_name': 'Dave Peck', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Dave Peck', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024409374', 'display_name': 'Carolina Perdomo Ortiz', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Carolina Perdomo Ortiz', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007743642', 'display_name': 'Martin Schillo', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Martin Schillo', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112753364', 'display_name': 'Ambika Singh', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Ambika Singh', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089355202', 'display_name': 'Ralph Tiedt', 'orcid': 'https://orcid.org/0000-0002-9825-859X'}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Ralph Tiedt', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040057002', 'display_name': 'Simone Tortoioli', 'orcid': 'https://orcid.org/0000-0002-5652-4124'}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Simone Tortoioli', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041829403', 'display_name': 'Silvia Buonamici', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Silvia Buonamici', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071800834', 'display_name': 'Filip Janků', 'orcid': 'https://orcid.org/0000-0002-8123-4065'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Filip Janku', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049853983', 'display_name': 'Owen B. Wallace', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Owen Wallace', 'raw_affiliation_strings': ['2Monte Rosa Therapeutics, Inc., Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '2Monte Rosa Therapeutics, Inc., Boston, MA.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5017436511', 'display_name': 'Bernhard Fasching', 'orcid': None}, 'institutions': [], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Bernhard Fasching', 'raw_affiliation_strings': ['1Monte Rosa Therapeutics, Inc., Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '1Monte Rosa Therapeutics, Inc., Basel, Switzerland;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.781, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.499258, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 84, 'max': 87}, 'biblio': {'volume': '83', 'issue': '7_Supplement', 'first_page': '3449', 'last_page': '3449'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11482', 'display_name': 'RNA modifications and cancer', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11482', 'display_name': 'RNA modifications and cancer', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10521', 'display_name': 'RNA and protein synthesis mechanisms', 'score': 0.9785, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10583', 'display_name': 'Cancer-related Molecular Pathways', 'score': 0.9757, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/polysome', 'display_name': 'Polysome', 'score': 0.4334465}], 'concepts': [{'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6049752}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.46871012}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.46629614}, {'id': 'https://openalex.org/C65666806', 'wikidata': 'https://www.wikidata.org/wiki/Q970614', 'display_name': 'Polysome', 'level': 5, 'score': 0.4334465}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.43283862}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3374694}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.24720183}, {'id': 'https://openalex.org/C67705224', 'wikidata': 'https://www.wikidata.org/wiki/Q11053', 'display_name': 'RNA', 'level': 3, 'score': 0.16539106}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.10904303}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.088369966}, {'id': 'https://openalex.org/C88478588', 'wikidata': 'https://www.wikidata.org/wiki/Q42244', 'display_name': 'Ribosome', 'level': 4, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2023-3449', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2082860237', 'https://openalex.org/W2031625915', 'https://openalex.org/W2030669399', 'https://openalex.org/W2023923174', 'https://openalex.org/W1995329946', 'https://openalex.org/W1990338613', 'https://openalex.org/W1968186479', 'https://openalex.org/W1964211057', 'https://openalex.org/W1490634076', 'https://openalex.org/W1012033650'], 'abstract_inverted_index': {'Abstract': [0], 'MYC': [1, 209, 286], 'transcription': [2, 210], 'factors': [3], 'are': [4, 32, 251], 'well-established': [5], 'drivers': [6], 'of': [7, 48, 73, 95, 167, 253, 275, 285, 292, 312, 322, 348, 359, 459, 471, 481], 'human': [8], 'cancers': [9, 31, 402, 473], 'but': [10], 'despite': [11], 'being': [12], 'amongst': [13], 'the': [14, 49, 65, 152, 164, 202, 230, 241, 272, 283, 309, 319, 379, 469, 482], 'most': [15], 'frequently': [16], 'altered': [17], 'oncogenes,': [18], 'no': [19, 294], 'approved': [20], 'therapy': [21], 'targeting': [22, 64, 201], 'MYC-driven': [23, 30, 81, 117, 315, 396], 'tumors': [24], 'has': [25], 'been': [26], 'developed': [27], 'to': [28, 34, 37, 108, 174, 180, 196, 214, 282], 'date.': [29], 'known': [33], 'be': [35], 'addicted': [36], 'protein': [38, 74, 203], 'translation.': [39], 'This': [40], 'addiction': [41, 477], 'creates': [42], 'a': [43, 55, 70, 78, 88, 110, 186, 268, 386], 'dependency': [44], 'on': [45, 148], 'critical': [46], 'components': [47], 'translational': [50, 254, 476], 'machinery': [51, 206], 'providing': [52], 'in': [53, 116, 229, 271, 280, 299, 302, 314, 326, 336, 365, 378, 385, 391], 'turn': [54, 281], 'unique': [56], 'opportunity': [57], 'for': [58, 80, 468, 485], 'therapeutic': [59], 'intervention.': [60], 'We': [61, 156], 'hypothesized': [62], 'that': [63, 163, 225], 'translation': [66, 204], 'termination': [67], 'factor': [68], 'GSPT1,': [69, 293], 'key': [71], 'regulator': [72], 'synthesis,': [75], 'would': [76], 'constitute': [77], 'vulnerability': [79], 'tumors.': [82], 'Herein': [83], 'we': [84], 'further': [85, 157, 376], 'describe': [86], 'MRT-2359': [87, 97, 144, 228, 313, 323, 332, 382], 'potent,': [89], 'selective': [90, 310], 'and': [91, 106, 112, 124, 133, 151, 191, 194, 221, 246, 256, 263, 338, 342, 369, 403, 494], 'orally': [92, 353, 462], 'bioavailable': [93, 463], 'degrader': [94], 'GSPT1.': [96], 'was': [98, 297, 324], 'rationally': [99], 'designed': [100], 'using': [101, 159, 259], 'our': [102], 'QuEENTM': [103], 'discovery': [104], 'engine': [105], 'optimized': [107], 'achieve': [109], 'profound': [111], 'preferential': [113, 334], 'antiproliferative': [114], 'activity': [115, 145, 311, 321, 335, 361], 'cell': [118, 129, 135, 235], 'lines,': [119, 307], 'such': [120, 216], 'as': [121], 'high': [122, 234, 340, 399], 'N-': [123, 169, 190, 231, 276, 304, 337], 'L-MYC': [125, 171, 192, 233, 278, 306, 339], 'mRNA': [126], 'expressing': [127], 'non-small': [128], 'lung': [130, 136, 316, 328, 367, 472], 'cancer': [131, 137, 368, 393], '(NSCLC)': [132], 'small': [134], '(SCLC)': [138], 'lines.': [139], 'In': [140], 'line': [141], 'with': [142, 227, 395, 474], 'expectations,': [143], 'is': [146, 172, 383], 'dependent': [147], 'both': [149], 'CRBN': [150], 'GSPT1': [153, 464], 'G-loop': [154], 'degron.': [155], 'demonstrate': [158], 'an': [160, 461], 'inducible': [161], 'system': [162], 'sole': [165], 'expression': [166, 193], 'either': [168], 'or': [170, 207, 232, 277, 305, 355], 'sufficient': [173], 'sensitize': [175], 'initially': [176], 'resistant': [177], 'NSCLC': [178, 341], 'cells': [179], 'MRT-2359.': [181, 197], 'These': [182, 249], 'studies': [183, 265], 'therefore': [184], 'establish': [185], 'causal': [187], 'link': [188], 'between': [189], 'sensitivity': [195], 'Unlike': [198], 'MRT-2359,': [199, 460], 'agents': [200], 'initiation': [205], 'repressing': [208], '(CDK9': [211], 'inhibitor)': [212], 'failed': [213], 'show': [215], 'differential': [217], 'activity.': [218], 'Mechanistically,': [219], 'RiboSeq': [220], 'polysome': [222], 'profiling': [223], 'revealed': [224], 'treatment': [226, 470], 'lines': [236], 'induces': [237], 'ribosome': [238], 'stalling': [239], 'at': [240], 'stop': [242], 'codon,': [243], 'increased': [244], 'monosomes': [245], 'decreased': [247], 'polysomes.': [248], 'changes': [250], 'indicative': [252], 'repression': [255], 'were': [257, 362], 'confirmed': [258], 'puromycilation': [260], 'assays.': [261], 'Proteomics': [262], 'RNAseq': [264], 'finally': [266], 'demonstrated': [267, 333], 'significant': [269], 'reduction': [270], 'total': [273], 'levels': [274, 358], 'leading': [279], 'downmodulation': [284], 'target': [287], 'genes.': [288], 'Despite': [289], 'robust': [290], 'degradation': [291], 'marked': [295], 'effect': [296], 'observed': [298, 364], 'these': [300, 373], 'assays': [301], 'low': [303], 'confirming': [308], 'cancers.': [317], 'Last,': [318], 'anti-tumor': [320, 360], 'assessed': [325], '>80': [327], 'patient-derived': [329], 'xenografts': [330], '(PDXs).': [331], 'SCLC': [343], 'PDXs,': [344], 'including': [345], 'numerous': [346], 'instances': [347], 'tumor': [349], 'regressions,': [350], 'when': [351], 'dosed': [352], 'daily': [354], 'intermittently.': [356], 'Similar': [357], 'also': [363], 'neuroendocrine': [366, 401], 'lymphoma': [370, 407], 'PDXs.': [371], 'Together': [372], 'results': [374], 'warrant': [375], 'investigations': [377], 'clinic.': [380], 'Oral': [381], 'currently': [384], 'Phase': [387], '1/2': [388], 'clinical': [389], 'trial': [390], 'selected': [392], 'patients': [394], 'NSCLC,': [397], 'SCLC,': [398], 'grade': [400], 'diffuse': [404], 'large': [405], 'B-cell': [406], '(NCT05546268).': [408], 'Citation': [409], 'Format:': [410], 'Gerald': [411], 'Gavory,': [412], 'Mahmoud': [413], 'Ghandi,': [414], 'Anne-Cecile': [415], 'd’Alessandro,': [416], 'Debora': [417], 'Bonenfant,': [418], 'Maciej': [419], 'Cabanski,': [420], 'Lisa': [421], 'Cantagallo,': [422], 'Agustin': [423], 'Chicas,': [424], 'Qian': [425], 'Chen,': [426], 'Anna': [427], 'Diesslin,': [428], 'Christopher': [429], 'King,': [430], 'Vittoria': [431], 'Massafra,': [432], 'Rajiv': [433], 'Narayan,': [434], 'Arnaud': [435], 'Osmont,': [436], 'Dave': [437], 'Peck,': [438], 'Carolina': [439], 'Perdomo': [440], 'Ortiz,': [441], 'Martin': [442], 'Schillo,': [443], 'Ambika': [444], 'Singh,': [445], 'Ralph': [446], 'Tiedt,': [447], 'Simone': [448], 'Tortoioli,': [449], 'Silvia': [450], 'Buonamici,': [451], 'Filip': [452], 'Janku,': [453], 'Owen': [454], 'Wallace,': [455], 'Bernhard': [456], 'Fasching.': [457], 'Development': [458], 'molecular': [465], 'glue': [466], 'degrader,': [467], 'MYC-induced': [475], '[abstract].': [478], 'In:': [479], 'Proceedings': [480], 'American': [483], 'Association': [484], 'Cancer': [486, 505], 'Research': [487], 'Annual': [488], 'Meeting': [489], '2023;': [490], 'Part': [491], '1': [492], '(Regular': [493], 'Invited': [495], 'Abstracts);': [496], '2023': [497], 'Apr': [498], '14-19;': [499], 'Orlando,': [500], 'FL.': [501], 'Philadelphia': [502], '(PA):': [503], 'AACR;': [504], 'Res': [506], '2023;83(7_Suppl):Abstract': [507], 'nr': [508], '3449.': [509]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4362545568', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}], 'updated_date': '2025-01-09T21:22:17.204334', 'created_date': '2023-04-06'}